Drug recall · July 22, 2015
Rifampin for Injection recall
Why: Failed Impurities/Degradation Specifications; out-of-specification for color, impurity, and degradation
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Rifampin for Injection, USP 600mg/vial in a 20mL vial, Rx only, Manufactured for Fresenius Kabi LLC 3 Corporate Drive, Lake Zurich, IL, 60047, by Fresenius Kabi LLC, 2020 N Ruby Street, Melrose Park, IL 60160. NDC 63323-351-20
- Lots / codes
Lot #: 6109469, 6109470, Exp 10/2016
- Quantity
- 7,593 vials
- Company
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Distribution
- Nationwide,Hawaii, and Puerto Rico
- Initiated
- June 4, 2015 · Voluntary: Firm initiated
- Classified
- July 14, 2015
- Reported
- July 22, 2015
- Ended
- May 19, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Rifampin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.